Source: Canadian Manufacturing

Jubilant: Canada continues to invest in domestic vaccine production

Investment in Jubilant HollisterStier will strengthen Canada's biomanufacturing capacity for vaccine and therapeutics production.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Chris Preti's photo - President of Jubilant

President

Chris Preti

CEO Approval Rating

82/100

Read more